Web Results

Amprenavir - Wikipedia


Amprenavir is a protease inhibitor used to treat HIV infection. It was approved by the Food and Drug Administration on April 15, 1999, for twice-a-day dosing ...

Amprenavir: Indications, Side Effects, Warnings - Drugs.com


Easy to read patient leaflet for amprenavir. Includes indications, proper use, special instructions, precautions, and possible side effects.

amprenavir, Agenerase: Drug Facts, Side Effects and Dosing


Amprenavir (Agenerase - discontinued brand) is a drug prescribed to treat infections with HIV. Side effects, drug interactions, and pregnancy safety information is ...

Agenerase Capsules (Amprenavir Capsules): Side Effects ... - RxList


Jul 16, 2008 ... Learn about Agenerase Capsules (Amprenavir Capsules) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, ...

Amprenavir (Agenerase)


Jan 25, 2001 ... Approval. Amprenavir was approved by the U.S. Food and Drug Administration ( FDA) in 1999 for use in adults and children with HIV infection.

Agenerase (amprenavir) - CenterWatch


Agenerase (amprenavir): For the treatment of HIV-1 infection.. New approved drug details including side effects, uses and general information.

Buy Amprenavir | HIV Protease inhibitor | Price | IC50 | Research only


Amprenavir is an human immunodeficiency virus (HIV) protease inhibitor with IC50 of 14.6 ± 12.5 ng/ml for wild-type HIV isolates. Order Amprenavir ( Agenerase) ...

Amprenavir (Agenerase) | aidsinfonet.org | The AIDS InfoNet


Manufacture of amprenavir was discontinued in October 2007. It is being replaced by fosamprenavir (see fact sheet 448). Fosamprenavir is a pro-drug of ...

RCSB PDB - 1T7J: crystal structure of inhibitor amprenavir in ...


1T7J: Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor.

Amprenavir ≥98% (HPLC) | Sigma-Aldrich


Sigma-Aldrich offers Sigma-SML0685, Amprenavir for your research needs. Find product specific information including CAS, MSDS, protocols and references.

More Info

DrugBank: Amprenavir


Accession Number, DB00701 (APRD00605). Type, Small Molecule. Groups, Approved. Description, Amprenavir is a protease inhibitor used to treat HIV infection ...

amprenavir | C25H35N3O6S - PubChem


Amprenavir is a Protease Inhibitor. The mechanism of action of amprenavir is as a HIV Protease Inhibitor, and Cytochrome P450 3A4 Inhibitor, and Cytochrome ...

agenerase - FDA


Amprenavir is a white to cream-colored solid with a solubility of approximately 0.04 mg/mL in water at 25°C. AGENERASE Capsules are available for oral ...